Selected publications
-
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: A multicentre, first-in-human, open-label, phase 1-2 study.
The lancet oncology.
2017
Academic Article
GET IT
Times cited: 16 - Independent Prognostic Significance of Monosomy 17 and Impact of Karyotype Complexity in Monosomal Karyotype/Complex Karyotype Acute Myeloid Leukemia: Results from Four ECOG-ACRIN Prospective Therapeutic Trials. Leukemia Research. 2017 Academic Article GET IT
-
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): A randomised, controlled, double-blind, multinational, phase 3 study.
The lancet oncology.
2015
Academic Article
GET IT
Times cited: 53 -
Acute myeloid leukemia, version 2.2013 featured updates to the NCCN guidelines.
JNCCN Journal of the National Comprehensive Cancer Network.
2013
Review
GET IT
Times cited: 73 -
Acute myeloid leukemia.
JNCCN Journal of the National Comprehensive Cancer Network.
2012
Academic Article
GET IT
Times cited: 141 -
Acute myeloid leukemia: Clinical practice guidelines in oncology.
JNCCN Journal of the National Comprehensive Cancer Network.
2011
Review
GET IT
Times cited: 40